In 2023, the rate of hospital discharges for leiomyoma of the uterus in Canada was 45.2 per hundred thousand persons. The forecasted data for 2024 to 2028 shows a declining trend, starting at 43.8 and decreasing to 38.5. The year-on-year percentage change indicates a consistent decline, with approximately 3.4% on average annually. The compound annual growth rate (CAGR) over the five-year period is expected to reflect a steady decrease, illustrating ongoing improvements in medical management or shifting demographic factors.
Future trends to watch for include advancements in non-surgical interventions and public health measures that may further reduce hospital discharge rates. Additionally, monitoring demographic shifts and healthcare policy changes will be crucial in understanding long-term projections.